{"frames":[{"target":{"name":"Medical_specialties","spans":[{"start":1,"end":2,"text":"medicine"}]},"annotationSets":[{"rank":0,"score":4.867614713043204,"frameElements":[{"name":"Specialty","spans":[{"start":0,"end":2,"text":"Nature medicine"}]}]}]}],"tokens":["Nature","medicine","."]}
{"frames":[{"target":{"name":"Aiming","spans":[{"start":0,"end":1,"text":"Targeting"}]},"annotationSets":[{"rank":0,"score":40.176745582356226,"frameElements":[]}]},{"target":{"name":"Building_subparts","spans":[{"start":2,"end":3,"text":"cell"}]},"annotationSets":[{"rank":0,"score":15.538329879389696,"frameElements":[{"name":"Building_part","spans":[{"start":2,"end":3,"text":"cell"}]}]}]},{"target":{"name":"Gesture","spans":[{"start":4,"end":5,"text":"signaling"}]},"annotationSets":[{"rank":0,"score":27.882018844861864,"frameElements":[]}]},{"target":{"name":"Dimension","spans":[{"start":9,"end":10,"text":"large"}]},"annotationSets":[{"rank":0,"score":21.703216032579608,"frameElements":[{"name":"Object","spans":[{"start":10,"end":11,"text":"B"}]},{"name":"Dimension","spans":[{"start":9,"end":10,"text":"large"}]}]}]},{"target":{"name":"Building_subparts","spans":[{"start":11,"end":12,"text":"cell"}]},"annotationSets":[{"rank":0,"score":15.38209243133494,"frameElements":[{"name":"Building_part","spans":[{"start":11,"end":12,"text":"cell"}]}]}]}],"tokens":["Targeting","B","cell","receptor","signaling","with","ibrutinib","in","diffuse","large","B","cell","lymphoma","."]}
{"frames":[{"target":{"name":"Cardinal_numbers","spans":[{"start":1,"end":2,"text":"two"}]},"annotationSets":[{"rank":0,"score":26.87385757209652,"frameElements":[{"name":"Number","spans":[{"start":1,"end":2,"text":"two"}]}]}]},{"target":{"name":"Importance","spans":[{"start":2,"end":3,"text":"major"}]},"annotationSets":[{"rank":0,"score":53.27000229191128,"frameElements":[{"name":"Factor","spans":[{"start":3,"end":4,"text":"subtypes"}]}]}]},{"target":{"name":"Dimension","spans":[{"start":6,"end":7,"text":"large"}]},"annotationSets":[{"rank":0,"score":21.798784113663803,"frameElements":[{"name":"Object","spans":[{"start":7,"end":8,"text":"B"}]},{"name":"Dimension","spans":[{"start":6,"end":7,"text":"large"}]}]}]},{"target":{"name":"Building_subparts","spans":[{"start":8,"end":9,"text":"cell"}]},"annotationSets":[{"rank":0,"score":15.211339271756497,"frameElements":[{"name":"Building_part","spans":[{"start":8,"end":9,"text":"cell"}]}]}]},{"target":{"name":"Locale_by_use","spans":[{"start":21,"end":22,"text":"center"}]},"annotationSets":[{"rank":0,"score":34.078835107302936,"frameElements":[{"name":"Locale","spans":[{"start":21,"end":22,"text":"center"}]}]}]},{"target":{"name":"Similarity","spans":[{"start":29,"end":30,"text":"distinct"}]},"annotationSets":[{"rank":0,"score":53.63474331186854,"frameElements":[{"name":"Entities","spans":[{"start":30,"end":31,"text":"mechanisms"}]}]}]},{"target":{"name":"Means","spans":[{"start":30,"end":31,"text":"mechanisms"}]},"annotationSets":[{"rank":0,"score":17.490790277212163,"frameElements":[{"name":"Means","spans":[{"start":30,"end":31,"text":"mechanisms"}]},{"name":"Descriptor","spans":[{"start":29,"end":30,"text":"distinct"}]}]}]},{"target":{"name":"Getting","spans":[{"start":35,"end":36,"text":"acquiring"}]},"annotationSets":[{"rank":0,"score":54.63527564325339,"frameElements":[{"name":"Recipient","spans":[{"start":33,"end":34,"text":"ABC"}]},{"name":"Theme","spans":[{"start":36,"end":37,"text":"mutations"}]}]}]},{"target":{"name":"Purpose","spans":[{"start":38,"end":39,"text":"target"}]},"annotationSets":[{"rank":0,"score":35.68683658111219,"frameElements":[{"name":"Goal","spans":[{"start":39,"end":43,"text":"the B cell receptor"}]},{"name":"Agent","spans":[{"start":37,"end":38,"text":"that"}]}]}]},{"target":{"name":"Building_subparts","spans":[{"start":41,"end":42,"text":"cell"}]},"annotationSets":[{"rank":0,"score":15.386941484984305,"frameElements":[{"name":"Building_part","spans":[{"start":41,"end":42,"text":"cell"}]}]}]},{"target":{"name":"Duration_attribute","spans":[{"start":48,"end":49,"text":"chronic"}]},"annotationSets":[{"rank":0,"score":9.159829772132984,"frameElements":[]}]},{"target":{"name":"Being_active","spans":[{"start":49,"end":50,"text":"active"}]},"annotationSets":[{"rank":0,"score":78.1765895094293,"frameElements":[]}]}],"tokens":["The","two","major","subtypes","of","diffuse","large","B","cell","lymphoma","-LRB-","DLBCL","-RRB-","-activated","B","cell-like","-LRB-","ABC","-RRB-","and","germinal","center","B","cell-like","-LRB-","GCB","-RRB-","-arise","by","distinct","mechanisms",",","with","ABC","selectively","acquiring","mutations","that","target","the","B","cell","receptor","-LRB-","BCR","-RRB-",",","fostering","chronic","active","BCR","signaling","-LRB-","1","-RRB-","."]}
{"frames":[{"target":{"name":"Inclusion","spans":[{"start":3,"end":4,"text":"has"}]},"annotationSets":[{"rank":0,"score":32.714732744478404,"frameElements":[{"name":"Part","spans":[{"start":4,"end":38,"text":"a similar to 40 % cure rate with currently available therapies , which is worse than the rate for GCB DLBCL , and highlights the need for ABC subtype-specific treatment strategies -LRB- 2 -RRB-"}]},{"name":"Total","spans":[{"start":0,"end":3,"text":"The ABC subtype"}]}]}]},{"target":{"name":"Similarity","spans":[{"start":5,"end":6,"text":"similar"}]},"annotationSets":[{"rank":0,"score":58.192502191334455,"frameElements":[{"name":"Entity_1","spans":[{"start":4,"end":5,"text":"a"}]},{"name":"Entity_2","spans":[{"start":6,"end":25,"text":"to 40 % cure rate with currently available therapies , which is worse than the rate for GCB DLBCL"}]}]}]},{"target":{"name":"Cardinal_numbers","spans":[{"start":7,"end":8,"text":"40"}]},"annotationSets":[{"rank":0,"score":24.755382388807057,"frameElements":[{"name":"Number","spans":[{"start":7,"end":8,"text":"40"}]},{"name":"Entity","spans":[{"start":9,"end":10,"text":"cure"}]}]}]},{"target":{"name":"Cure","spans":[{"start":9,"end":10,"text":"cure"}]},"annotationSets":[{"rank":0,"score":40.9798454653824,"frameElements":[]}]},{"target":{"name":"Frequency","spans":[{"start":10,"end":11,"text":"rate"}]},"annotationSets":[{"rank":0,"score":25.332950030024897,"frameElements":[]}]},{"target":{"name":"Temporal_collocation","spans":[{"start":12,"end":13,"text":"currently"}]},"annotationSets":[{"rank":0,"score":27.860177991502418,"frameElements":[]}]},{"target":{"name":"Cure","spans":[{"start":14,"end":15,"text":"therapies"}]},"annotationSets":[{"rank":0,"score":48.37012513209186,"frameElements":[]}]},{"target":{"name":"Desirability","spans":[{"start":18,"end":19,"text":"worse"}]},"annotationSets":[{"rank":0,"score":23.26036553210995,"frameElements":[{"name":"Evaluee","spans":[{"start":16,"end":17,"text":"which"}]}]}]},{"target":{"name":"Frequency","spans":[{"start":21,"end":22,"text":"rate"}]},"annotationSets":[{"rank":0,"score":27.788152706046628,"frameElements":[]}]},{"target":{"name":"Have_as_requirement","spans":[{"start":29,"end":30,"text":"need"}]},"annotationSets":[{"rank":0,"score":12.631039342326444,"frameElements":[]}]},{"target":{"name":"Cure","spans":[{"start":33,"end":34,"text":"treatment"}]},"annotationSets":[{"rank":0,"score":47.05602779734238,"frameElements":[]}]},{"target":{"name":"Cardinal_numbers","spans":[{"start":36,"end":37,"text":"2"}]},"annotationSets":[{"rank":0,"score":26.3966735700671,"frameElements":[{"name":"Number","spans":[{"start":36,"end":37,"text":"2"}]}]}]}],"tokens":["The","ABC","subtype","has","a","similar","to","40","%","cure","rate","with","currently","available","therapies",",","which","is","worse","than","the","rate","for","GCB","DLBCL",",","and","highlights","the","need","for","ABC","subtype-specific","treatment","strategies","-LRB-","2","-RRB-","."]}
{"frames":[{"target":{"name":"Medical_conditions","spans":[{"start":10,"end":11,"text":"tumors"}]},"annotationSets":[{"rank":0,"score":34.35232136325519,"frameElements":[]}]},{"target":{"name":"Response","spans":[{"start":12,"end":13,"text":"respond"}]},"annotationSets":[{"rank":0,"score":38.95447801987987,"frameElements":[{"name":"Agent","spans":[{"start":0,"end":1,"text":"We"}]}]}]}],"tokens":["We","hypothesized","that","ABC",",","but","not","GCB",",","DLBCL","tumors","would","respond","to","ibrutinib",",","an","inhibitor","of","BCR","signaling","."]}
{"frames":[{"target":{"name":"Trial","spans":[{"start":5,"end":6,"text":"trial"}]},"annotationSets":[{"rank":0,"score":46.14827973606994,"frameElements":[]}]},{"target":{"name":"Participation","spans":[{"start":7,"end":8,"text":"involved"}]},"annotationSets":[{"rank":0,"score":52.29603638746941,"frameElements":[{"name":"Event","spans":[{"start":8,"end":15,"text":"80 subjects with relapsed or refractory DLBCL"}]}]}]},{"target":{"name":"Topic","spans":[{"start":9,"end":10,"text":"subjects"}]},"annotationSets":[{"rank":0,"score":25.650342738580143,"frameElements":[]}]},{"target":{"name":"Creating","spans":[{"start":17,"end":18,"text":"produced"}]},"annotationSets":[{"rank":0,"score":74.14267109002724,"frameElements":[]}]},{"target":{"name":"Completeness","spans":[{"start":18,"end":19,"text":"complete"}]},"annotationSets":[{"rank":0,"score":12.48141050656087,"frameElements":[{"name":"Whole","spans":[{"start":21,"end":22,"text":"responses"}]}]}]},{"target":{"name":"Process_completed_state","spans":[{"start":20,"end":21,"text":"partial"}]},"annotationSets":[{"rank":0,"score":1.898831749751291,"frameElements":[]}]},{"target":{"name":"Response","spans":[{"start":21,"end":22,"text":"responses"}]},"annotationSets":[{"rank":0,"score":43.27871598327997,"frameElements":[]}]},{"target":{"name":"Sole_instance","spans":[{"start":36,"end":37,"text":"only"}]},"annotationSets":[{"rank":0,"score":2.8597335327308118,"frameElements":[{"name":"Type","spans":[{"start":37,"end":38,"text":"5"}]}]}]},{"target":{"name":"People_by_jurisdiction","spans":[{"start":43,"end":44,"text":"subjects"}]},"annotationSets":[{"rank":0,"score":18.030307513812737,"frameElements":[{"name":"Person","spans":[{"start":43,"end":44,"text":"subjects"}]}]}]}],"tokens":["In","a","phase","1/2","clinical","trial","that","involved","80","subjects","with","relapsed","or","refractory","DLBCL",",","ibrutinib","produced","complete","or","partial","responses","in","37","%","-LRB-","14/38","-RRB-","of","those","with","ABC","DLBCL",",","but","in","only","5","%","-LRB-","1/20","-RRB-","of","subjects","with","GCB","DLBCL","-LRB-","P","=","0.0106","-RRB-","."]}
{"frames":[{"target":{"name":"Medical_conditions","spans":[{"start":1,"end":2,"text":"tumors"}]},"annotationSets":[{"rank":0,"score":35.93829032808041,"frameElements":[]}]},{"target":{"name":"Response","spans":[{"start":5,"end":6,"text":"responded"}]},"annotationSets":[{"rank":0,"score":39.533847578827846,"frameElements":[{"name":"Agent","spans":[{"start":0,"end":5,"text":"ABC tumors with BCR mutations"}]}]}]},{"target":{"name":"Frequency","spans":[{"start":8,"end":9,"text":"frequently"}]},"annotationSets":[{"rank":0,"score":34.896141872908565,"frameElements":[{"name":"Event","spans":[{"start":6,"end":8,"text":"to ibrutinib"}]}]}]},{"target":{"name":"First_rank","spans":[{"start":22,"end":23,"text":"primary"}]},"annotationSets":[{"rank":0,"score":12.688743650009716,"frameElements":[{"name":"Item","spans":[{"start":23,"end":24,"text":"response"}]}]}]},{"target":{"name":"Response","spans":[{"start":23,"end":24,"text":"response"}]},"annotationSets":[{"rank":0,"score":40.55538296050918,"frameElements":[]}]},{"target":{"name":"Causation","spans":[{"start":37,"end":38,"text":"result"}]},"annotationSets":[{"rank":0,"score":68.01611639430607,"frameElements":[{"name":"Cause","spans":[{"start":38,"end":51,"text":"that is consistent with in vitro cooperation between the BCR and MYD88 pathways"}]}]}]},{"target":{"name":"Compatibility","spans":[{"start":40,"end":41,"text":"consistent"}]},"annotationSets":[{"rank":0,"score":17.589537944808015,"frameElements":[]}]},{"target":{"name":"Collaboration","spans":[{"start":44,"end":45,"text":"cooperation"}]},"annotationSets":[{"rank":0,"score":37.97612697139071,"frameElements":[{"name":"Undertaking","spans":[{"start":45,"end":51,"text":"between the BCR and MYD88 pathways"}]}]}]},{"target":{"name":"Roadways","spans":[{"start":50,"end":51,"text":"pathways"}]},"annotationSets":[{"rank":0,"score":73.16652705809781,"frameElements":[{"name":"Roadway","spans":[{"start":50,"end":51,"text":"pathways"}]}]}]}],"tokens":["ABC","tumors","with","BCR","mutations","responded","to","ibrutinib","frequently","-LRB-","5/9",";","55.5","%","-RRB-",",","especially","those","with","concomitant","myeloid","differentiation","primary","response","88","-LRB-","MYD88","-RRB-","mutations","-LRB-","4/5",";","80","%","-RRB-",",","a","result","that","is","consistent","with","in","vitro","cooperation","between","the","BCR","and","MYD88","pathways","."]}
{"frames":[{"target":{"name":"Concessive","spans":[{"start":0,"end":1,"text":"However"}]},"annotationSets":[{"rank":0,"score":5.875789320013224,"frameElements":[]}]},{"target":{"name":"Quantity","spans":[{"start":4,"end":5,"text":"number"}]},"annotationSets":[{"rank":0,"score":23.239396477892946,"frameElements":[{"name":"Q_Prop","spans":[{"start":3,"end":4,"text":"highest"}]},{"name":"Quantity","spans":[{"start":4,"end":5,"text":"number"}]},{"name":"Individuals","spans":[{"start":5,"end":7,"text":"of responses"}]}]}]},{"target":{"name":"Response","spans":[{"start":6,"end":7,"text":"responses"}]},"annotationSets":[{"rank":0,"score":40.939457429052496,"frameElements":[]}]},{"target":{"name":"Event","spans":[{"start":7,"end":8,"text":"occurred"}]},"annotationSets":[{"rank":0,"score":31.546667918701722,"frameElements":[{"name":"Time","spans":[{"start":8,"end":17,"text":"in ABC tumors that lacked BCR mutations -LRB- 9/29"}]},{"name":"Event","spans":[{"start":2,"end":7,"text":"the highest number of responses"}]}]}]},{"target":{"name":"Medical_conditions","spans":[{"start":10,"end":11,"text":"tumors"}]},"annotationSets":[{"rank":0,"score":37.30042954519926,"frameElements":[]}]},{"target":{"name":"Possession","spans":[{"start":12,"end":13,"text":"lacked"}]},"annotationSets":[{"rank":0,"score":40.177097204699145,"frameElements":[{"name":"Possession","spans":[{"start":13,"end":17,"text":"BCR mutations -LRB- 9/29"}]},{"name":"Owner","spans":[{"start":9,"end":11,"text":"ABC tumors"}]}]}]},{"target":{"name":"Statement","spans":[{"start":22,"end":23,"text":"suggesting"}]},"annotationSets":[{"rank":0,"score":111.49806226413271,"frameElements":[{"name":"Message","spans":[{"start":23,"end":41,"text":"that oncogenic BCR signaling in ABC does not require BCR mutations and might be initiated by non-genetic mechanisms"}]}]}]},{"target":{"name":"Intentionally_act","spans":[{"start":29,"end":30,"text":"does"}]},"annotationSets":[{"rank":0,"score":53.25697776353477,"frameElements":[{"name":"Act","spans":[{"start":24,"end":29,"text":"oncogenic BCR signaling in ABC"}]}]}]},{"target":{"name":"Have_as_requirement","spans":[{"start":31,"end":32,"text":"require"}]},"annotationSets":[{"rank":0,"score":19.475148219152363,"frameElements":[{"name":"Dependent","spans":[{"start":24,"end":29,"text":"oncogenic BCR signaling in ABC"}]},{"name":"Requirement","spans":[{"start":32,"end":34,"text":"BCR mutations"}]}]}]},{"target":{"name":"Likelihood","spans":[{"start":35,"end":36,"text":"might"}]},"annotationSets":[{"rank":0,"score":26.143896503529405,"frameElements":[{"name":"Hypothetical_event","spans":[{"start":32,"end":34,"text":"BCR mutations"}]}]}]},{"target":{"name":"Activity_start","spans":[{"start":37,"end":38,"text":"initiated"}]},"annotationSets":[{"rank":0,"score":71.31126688326367,"frameElements":[{"name":"Activity","spans":[{"start":38,"end":41,"text":"by non-genetic mechanisms"}]}]}]},{"target":{"name":"Means","spans":[{"start":40,"end":41,"text":"mechanisms"}]},"annotationSets":[{"rank":0,"score":16.774436137110275,"frameElements":[{"name":"Means","spans":[{"start":40,"end":41,"text":"mechanisms"}]},{"name":"Descriptor","spans":[{"start":39,"end":40,"text":"non-genetic"}]}]}]}],"tokens":["However",",","the","highest","number","of","responses","occurred","in","ABC","tumors","that","lacked","BCR","mutations","-LRB-","9/29",";","31","%","-RRB-",",","suggesting","that","oncogenic","BCR","signaling","in","ABC","does","not","require","BCR","mutations","and","might","be","initiated","by","non-genetic","mechanisms","."]}
{"frames":[{"target":{"name":"Causation","spans":[{"start":1,"end":2,"text":"results"}]},"annotationSets":[{"rank":0,"score":72.00854419487409,"frameElements":[]}]},{"target":{"name":"Taking_sides","spans":[{"start":2,"end":3,"text":"support"}]},"annotationSets":[{"rank":0,"score":61.74534005279244,"frameElements":[{"name":"Cognizer","spans":[{"start":0,"end":2,"text":"These results"}]}]}]},{"target":{"name":"Event","spans":[{"start":5,"end":6,"text":"development"}]},"annotationSets":[{"rank":0,"score":31.756084786070442,"frameElements":[{"name":"Event","spans":[{"start":4,"end":5,"text":"selective"}]}]}]},{"target":{"name":"Cure","spans":[{"start":10,"end":11,"text":"treatment"}]},"annotationSets":[{"rank":0,"score":43.5532377894228,"frameElements":[]}]}],"tokens":["These","results","support","the","selective","development","of","ibrutinib","for","the","treatment","of","ABC","DLBCL","."]}
